The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
Feature|Articles|March 5, 2025
Lancet Commission Redefines Clinical Obesity, Moving Beyond BMI
Author(s)Ashley Gallagher, MA
“The Commission reinforces that obesity is a disease and not due to lack of motivation, willpower, discipline, or laziness,” Robert F. Kushner said.
Advertisement
Advertisement
In January 2025, The Lancet Diabetes & Endocrinology published its Commission on the definition of clinical obesity as well as diagnostic criteria. With the new definitions, the Commission has identified preclinical obesity as a risk factor and clinical obesity as a stand-alone illness, according to the authors.
Related to this article
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled use, a new study finds.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
Advertisement
Advertisement